Direkt zum Inhalt

Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for neonatal infection

Auch verfügbar in

Several factors increase the risk of serious infection in term newborn infants, for example, the presence in the birth canal of a bacterium that causes infection in the newborn (group B streptococcus), rupture of membranes more than a day before delivery, or high temperature in the mother during labour. Some paediatricians routinely prescribe an antibiotic for the newborn infant if any of these factors is present, even if the infant appears to be completely well. Others believe that it is safe and appropriate to observe these infants and only treat those who develop signs of illness, or have other evidence of infection during the first day after birth. We found two small trials that addressed this question. Neither provided enough evidence to guide practice. A further larger randomized trial is needed.

Hintergrund

Early onset bacterial infection is an important cause of morbidity and mortality in newborn infants. Various factors that increase the risk of neonatal infection have been identified. It is unclear whether asymptomatic newborn infants born to mothers with one or more of these risk factors should receive antibiotics prophylactically rather than selectively if only clinical or microbiological evidence of sepsis emerges.

Zielsetzungen

To assess the effect of prophylactic versus selective antibiotic treatment for asymptomatic term neonates born to mothers with risk factors for neonatal infection.

Suchstrategie

We used the standard methods of the Cochrane Neonatal Review Group. We searched MEDLINE (1966 - May 2004), EMBASE (1980 - May 2004), LILACS (1982 - 2003), SciELO (1997 - 2003), the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 2004), and Centers for Disease Control and Prevention protocols and guidelines on the subject.

Auswahlkriterien

Randomized controlled trials, or trials using quasi-random methods of allocation, comparing the use of prophylactic versus selective antibiotics in asymptomatic neonates born to mothers with one or more risk factors for infection.

Datensammlung und ‐analyse

We extracted the data using the standard methods of the Cochrane Neonatal Review Group, with separate evaluation of trial quality and data extraction by three reviewers and synthesis of data using relative risk and risk difference. The pre-specified primary outcomes were neonatal mortality, systemic neonatal infection, and need for admission to a neonatal intensive care unit.

Hauptergebnisse

We identified two small trials undertaken in the 1970s. Both trials had methodological weaknesses. There was no evidence of an effect on any of the primary outcomes, but because the trials were underpowered, clinically important effect sizes may have been missed.

Schlussfolgerungen der Autoren

There are insufficient data from randomized controlled trials to guide clinical practice. A large randomized controlled trial is needed in asymptomatic term infants born to mothers with risk factors for infection in their babies, which compares the effect of prophylactic versus selective antibiotics on morbidity, mortality and costs.

Zitierung
Ungerer RLS, Lincetto O, McGuire W, Saloojee HH, Gülmezoglu AM. Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for neonatal infection. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003957. DOI: 10.1002/14651858.CD003957.pub2.

So verwenden wir Cookies

Wir verwenden notwendige Cookies, damit unsere Webseite funktioniert. Wir möchten auch optionale Cookies für Google Analytics setzen, um unsere Webseite zu verbessern. Solche optionalen Cookies setzen wir nur, wenn Sie dies zulassen. Wenn Sie dieses Programm aufrufen, wird ein Cookie auf Ihrem Gerät platziert, um Ihre Präferenzen zu speichern. Sie können Ihre Cookie-Einstellungen jederzeit ändern, indem Sie auf den Link "Cookie-Einstellungen" am Ende jeder Seite klicken.
Auf unserer Seite zu Cookies finden Sie weitere Informationen, wie diese Cookies funktionieren die Seite mit den Cookies.

Alle akzeptieren
Anpassen